Jean‐Michel Rondeau
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Enzyme Structure and Function, Chemical Synthesis and Analysis, Bone health and treatments, Various Chemistry Research Topics, Computational Drug Discovery Methods
Most-Cited Works
- → Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs(2006)223 cited
- → PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling(2013)219 cited
- → Novel NADPH-binding domain revealed by the crystal structure of aldose reductase(1992)191 cited
- → The BACE ‐1 inhibitor CNP 520 for prevention trials in Alzheimer's disease(2018)169 cited
- → Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy(2017)133 cited
- → Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery(2010)123 cited
- →